Abstract
An enzyme-responsive, paclitaxel-loaded nanoparticle is described and assessed in vivo in a human fibrosarcoma murine xenograft. This work represents a proof-of-concept study demonstrating the utility of enzyme-responsive nanoscale drug carriers capable of targeted accumulation and retention in tumor tissue in response to overexpressed endogenous enzymes.
Original language | English (US) |
---|---|
Pages (from-to) | 4611-4615 |
Number of pages | 5 |
Journal | Advanced Materials |
Volume | 27 |
Issue number | 31 |
DOIs | |
State | Published - Aug 1 2015 |
Keywords
- drug delivery
- enzyme-responsive
- nanomaterials
- self-assembly
- stimuli-responsive
ASJC Scopus subject areas
- Materials Science(all)
- Mechanics of Materials
- Mechanical Engineering